Accès ouvert
2023
other
OpenAlex
Lindsey Elizabeth Roeker, Christopher Paul Fox, Toby Andrew Eyre, Danielle M. Brander et autres
AbstractPurpose: Clinical trials of venetoclax reported negligible rates of clinical tumor lysis syndrome (TLS) in patients with chronic lymphocytic leukemia (CLL) when using an extended dose escalation schedule. We aimed to understand TLS prophylaxis, rates of select adverse events (AE), and impact …
Accès ouvert
2023
supplementary-materials
OpenAlex
Lindsey Elizabeth Roeker, Christopher Paul Fox, Toby Andrew Eyre, Danielle M. Brander et autres
Supplemental Figure 1.
Accès ouvert
2023
supplementary-materials
OpenAlex
Lindsey Elizabeth Roeker, Christopher Paul Fox, Toby Andrew Eyre, Danielle M. Brander et autres
Supplemental Table 1 and Supplemental Figure Legends
Accès ouvert
2023
other
OpenAlex
Lindsey Elizabeth Roeker, Christopher Paul Fox, Toby Andrew Eyre, Danielle M. Brander et autres
AbstractPurpose: Clinical trials of venetoclax reported negligible rates of clinical tumor lysis syndrome (TLS) in patients with chronic lymphocytic leukemia (CLL) when using an extended dose escalation schedule. We aimed to understand TLS prophylaxis, rates of select adverse events (AE), and impact …
Accès ouvert
2023
supplementary-materials
OpenAlex
Lindsey Elizabeth Roeker, Christopher Paul Fox, Toby Andrew Eyre, Danielle M. Brander et autres
Supplemental Figure 1.
Accès ouvert
2023
supplementary-materials
OpenAlex
Lindsey Elizabeth Roeker, Christopher Paul Fox, Toby Andrew Eyre, Danielle M. Brander et autres
Supplemental Table 1 and Supplemental Figure Legends
Accès ouvert
2022
conference-abstract
OpenAlex
Baha Abdelrahim, Mustafa Alam, Arun K. Singavi, Mohamad Hosam Horani
Abstract Patient is a 29-year-old female with PCOS and morbid obesity and recent admission for abdominal pain is found to have bilateral adrenal hemorrhage and prolonged PTT. Patient was found to be anemic with hemoglobin of 6.1 a week prior to presentation, …
2020
conference-abstract
OpenAlex
Ariel Kleman, Arun K. Singavi, Lauren Pommert, Michael T. Zimmerman et autres
Background: Patients (pts) diagnosed with multiple myeloma (MM) are at risk for developing secondary hematologic malignancies (SHM). The etiology of SHM-associated genetic alterations (GAs) is unclear. We hypothesized that the GAs present in MM-associated SHMs would have a distinct profile compared to …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Jeremy S. Abramson, Hana Lim, Friederike H. C. Kreisel, Arun K. Singavi et autres
De novo CD5+ diffuse large B-cell lymphomas (DLBCL) are a distinct subgroup of DLBCL with poor prognosis. However the role of rituximab-containing therapy and salvage stem cell transplantation in this patients’ population remain to be defined. We retrospectively reviewed clinical features and …
us
(code pays fourni par la source)
2020
conference-abstract
OpenAlex
Kaitlin Annunzio, Claire Griffiths, Igli Arapi, Matthew Lasowski et autres
759 Background: PC is a lethal disease with limited treatment options. We utilized Comprehensive Genomic Profiling (CGP) to identify putative prognostic and/or predictive biomarkers. Methods: We retrospectively reviewed PC patients (pts) at our institution who underwent CGP utilizing the Foundation One assay. …
us
(code pays fourni par la source)
2019
conference-abstract
OpenAlex
Ehab L. Atallah, Arun K. Singavi, Bradley W. Taylor, Arielle Baim et autres
Background: Tyrosine kinase inhibitor (TKI) therapy has led to phenomenal improvement in overall survival for patients with CML. Since TKI therapies were introduced and their results observed, very little innovative research has been conducted in CML. However, several important research directions remain, …
us
(code pays fourni par la source)
2019
article
OpenAlex
Nicholas L. Wright, Ensi Voshtina, Gemlyn George, Arun K. Singavi et autres
us
(code pays fourni par la source)